Ancora Advisors LLC Invests $47.63 Million in Sotera Health Company $SHC

Key Points

• Ancora Advisors acquired 2.68 million Sotera Health shares worth approximately $47.6 million, representing about 0.94% of the company and 0.9% of Ancora’s portfolio. Institutional investors collectively own 91.03% of SHC.
• Sotera Health exceeded quarterly expectations, reporting $0.26 in EPS versus $0.24 expected and $321.38 million in revenue, up 9.2% year over year. The company issued fiscal 2026 EPS guidance of $0.95–$1.01.
• Analysts maintain a positive outlook, with a “Moderate Buy” consensus and an average price target of $21.50. However, insiders sold about 1.29 million shares worth $24.0 million over the past three months.

Ancora Advisors LLC acquired a new stake in Sotera Health Company (NASDAQ:SHC - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 2,683,637 shares of the company's stock, valued at approximately $47,635,000. Sotera Health comprises about 0.9% of Ancora Advisors LLC's holdings, making the stock its 18th biggest holding. Ancora Advisors LLC owned approximately 0.94% of Sotera Health as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in SHC. BlackRock Inc. acquired a new position in Sotera Health during the second quarter worth $428,635,000. Sculptor Capital LP lifted its stake in Sotera Health by 3.4% in the 1st quarter. Sculptor Capital LP now owns 21,717,728 shares of the company's stock valued at $311,432,000 after purchasing an additional 717,728 shares during the last quarter. Vanguard Group Inc. lifted its stake in Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company's stock valued at $339,189,000 after purchasing an additional 2,756,583 shares during the last quarter. Sachem Head Capital Management LP grew its holdings in Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company's stock worth $205,418,000 after purchasing an additional 3,735,000 shares during the period. Finally, Janus Henderson Group PLC grew its holdings in Sotera Health by 35.3% during the first quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company's stock worth $131,413,000 after purchasing an additional 2,390,132 shares during the period. 91.03% of the stock is owned by institutional investors.

Sotera Health Stock Up 1.8%

Sotera Health stock opened at $19.51 on Wednesday. The company's 50-day moving average price is $17.89 and its two-hundred day moving average price is $16.36. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The stock has a market cap of $5.57 billion, a P/E ratio of 34.23 and a beta of 1.77. Sotera Health Company has a twelve month low of $13.09 and a twelve month high of $19.85.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million during the quarter, compared to analysts' expectations of $309.70 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. The business's revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. As a group, analysts expect that Sotera Health Company will post 0.86 EPS for the current year.

Insider Activity at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the company's stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares of the company's stock, valued at $73,433,770.50. This represents a 17.64% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. 15.36% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Citigroup boosted their price target on Sotera Health from $23.00 to $25.00 and gave the stock a "buy" rating in a research report on Friday, August 7th. Barclays lifted their target price on Sotera Health from $19.00 to $22.00 and gave the stock an "overweight" rating in a research note on Friday, August 7th. UBS Group set a $19.00 target price on Sotera Health in a report on Wednesday, June 24th. The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, June 5th. They issued a "buy" rating and a $20.00 price target on the stock. Finally, JPMorgan Chase & Co. raised their price target on Sotera Health from $16.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $21.50.

Sotera Health Company Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source